In early 1994, Dow Corning Corp. debates whether part of a proposed $ 4.2 billion settlement in product liability. Specifically, the company must decide whether to contribute $ 2 billion to a class action lawsuit by women suffering from connective tissue diseases, autoimmune diseases and other medical conditions, terminate allegedly filed because of defective silicone breast implants. While denying any wrongdoing, is accused of Dow Corning intentionally withheld information on health r … Read more »

In early 1994, Dow Corning Corp. debates whether part of a proposed $ 4.2 billion settlement in product liability. Specifically, the company must decide whether to contribute $ 2 billion to a class action lawsuit by women suffering from connective tissue diseases, autoimmune diseases and other medical conditions, terminate allegedly filed because of defective silicone breast implants. While denying any wrongdoing Dow Corning is accused deliberately withheld information on health risks associated with their implants over several decades.
«Hide

from
Willis Emmons,
Greg Keller,
Monica Brand
Source: Harvard Business School
20 pages.
Publication Date: Nov 14, 1994. Prod #: 795047-PDF-ENG
Dow Corning and the Breast Implant Controversy (A) HBR case solution